 |
Return Create A Forum - Home |
 |
--------------------------------------------------------- |
|
MS Speaks |
 |
https://msspeaks.createaforum.com |
|
--------------------------------------------------------- |
|
***************************************************** |
|
Return to: OCREVUS (ocrelizumab) |
|
***************************************************** |
|
#Post#: 4763-------------------------------------------------- |
|
Genentech updates Phase 3 Ocrevus high-dose study in people w/re |
|
lapsing MS |
|
By: agate Date: April 3, 2025, 2:07 pm |
|
--------------------------------------------------------- |
|
From BusinessWire.com (April 2, 2025)--"Genentech Provides |
|
Update on Phase III Ocrevus High-Dose Study in People with |
|
Relapsing Multiple Sclerosis": |
|
https://tinyurl.com/yenj9hcmhttp:// |
|
***************************************************** |
